Elastography in Liver Cell Failure
NCT06089785 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 77
Last updated 2023-10-18
Summary
1. evaluation of degree of spleen stiffness in liver cell failure patient by elastography.
2. correlation of degree of spleen stiffness and patient outcome
Conditions
- Liver Cell Damage
Interventions
- DEVICE
-
elastography
evaluation of degree of spleen stiffness in liver cell failure patient by elastography.
Sponsors & Collaborators
-
Omnia Saad Desoky Mohamed
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-10-31
- Primary Completion
- 2026-12-31
- Completion
- 2027-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy
NCT03499249 ·Status: COMPLETED ·Phase: PHASE2
-
GlycoCholic Acid Treatment for Patients With Inborn Errors in Bile Acid Synthesis
NCT01589523 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia
NCT06227624 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life and Nutritional Improvements in Cirrhotic Patients
NCT01842113 ·Status: TERMINATED ·Phase: PHASE4
-
Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
NCT05279586 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy
NCT06072521 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Fibrates in Pediatric Cholestasis
NCT03586674 ·Status: COMPLETED ·Phase: PHASE2
-
Regulation of FGF21 by Nutritional Challenges
NCT00968747 ·Status: COMPLETED ·Phase: NA
-
Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders
NCT00718627 ·Status: COMPLETED ·Phase: PHASE2
-
Restoring the Beneficial Effects of Enterohepatic Bile Salt Signalling by Chyme Reinfusion in Patients With a Double Enterostomy
NCT02990195 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency
NCT04147936 ·Status: COMPLETED ·Phase: NA
-
Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis
NCT00004441 ·Status: COMPLETED ·Phase: NA
-
Molecular Characterization for Understanding Biliary Atresia
NCT04272515 ·Status: RECRUITING ·Phase: NA
-
Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children
NCT04542473 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Application of n-3 Fatty to Patient of Jaundice
NCT03376945 ·Status: COMPLETED
-
Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)
NCT03632993 ·Status: COMPLETED ·Phase: PHASE2
-
Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury
NCT02010034 ·Status: COMPLETED ·Phase: NA
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Proxy-Reported Symptoms and Quality of Life Survey in Zellweger Spectrum Disorders
NCT03440905 ·Status: COMPLETED
-
N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure
NCT00248625 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
NCT01466894 ·Status: WITHDRAWN ·Phase: PHASE2
-
Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients
NCT01742013 ·Status: COMPLETED ·Phase: PHASE3
-
High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease
NCT05578404 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of Fatty Acid Composition of Triglycerides in Patients With Hypertriglyceridemia-induced Acute Pancreatitis
NCT04097990 ·Status: UNKNOWN ·Phase: NA
-
Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease
NCT00007033 ·Status: COMPLETED ·Phase: NA